Pharmacy Daily | Eyla approved for eyes

Eyla approved for eyes

EYLEA (aflibercept) has received FDA approval for the treatment of patients with wet (neovascular) age-related macular…

Skin gets scholarship

Skin gets scholarship

PD for Thu 24 Nov 2011

TGA pain killer controversy, Monash sponsorship, Pharmacy chemo changes, Actemra approval and much more…

Dispensary Corner 24 Nov 11

OTRIVINE needed immediately. A passionate opposition MP in South Korea went to extreme measures to block…

Insomnia approval

THE US FDA has approved Intermezzo (zolpidem tartrate sublingual tablets) for use as needed to treat…

Pharmacy chemo changes

PHARMACISTS should prepare for the revised arrangements for the Efficient Funding of Chemotherapy Drugs which will…

Remote WA risks

AUSTRALIANS who suffer major trauma injuries in remote Western Australia are four times more likely to…

Monash sponsorship

UNDERGRADUATE pharmacy students at Monash University, Melbourne, are set to benefit from a new ten-year sponsorship…

TGA pain killer controversy

THE Therapeutic Goods Administration’s decision to cancel all pain killers containing dextropropoxyphene (Capadex, Di-Gesic, Doloxene and…